Cargando…

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial

INTRODUCTION: Type 2 diabetes (T2D) is characterised by elevated plasma glucose, free fatty acid (FFA) and insulin concentrations, and this metabolic profile is linked to diabetic cardiomyopathy, a diastolic dysfunction at first and increased cardiovascular disease (CVD) risk. Shifting cardiac metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thirumathyam, Roopameera, Richter, Erik Arne, Goetze, Jens Peter, Fenger, Mogens, Van Hall, Gerrit, Dixen, Ulrik, Holst, Jens Juul, Madsbad, Sten, Vejlstrup, Niels, Madsen, Per Lav, Jørgensen, Nils Bruun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379482/ https://www.ncbi.nlm.nih.gov/pubmed/35953245 http://dx.doi.org/10.1136/bmjopen-2021-054100

Ejemplares similares

Hyperinsulinaemia and hyperglycaemia promote glucose utilization and storage during low- and high-intensity exercise
por: Mohebbi, Hamid, et al.
Publicado: (2019)

Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans
por: Stegenga, M E, et al.
Publicado: (2008)

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Fractionated free fatty acids and their relation to diabetes status after Roux‐en‐Y gastric bypass: A cohort study
por: Eriksen, Freja, et al.
Publicado: (2021)

Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans
por: Asmar, Meena, et al.
Publicado: (2010)

Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease
por: Anholm, Christian, et al.
Publicado: (2019)

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss()
por: Holst, Jens Juul, et al.
Publicado: (2018)

What is Diabetes Remission?
por: Holst, Jens J., et al.
Publicado: (2021)

Empagliflozin: Euglycaemic diabetic ketoacidosis, masking of hyperglycaemia and hyperglycosuria: case report
Publicado: (2022)

Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes
por: Bojer, Annemie Stege, et al.
Publicado: (2020)

Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study
por: Carlsson, Elin Rebecka, et al.
Publicado: (2019)

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Insulin resistance and hyperinsulinaemia in the development and progression of cancer
por: Godsland, Ian F.
Publicado: (2009)

Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
por: Carlsson, Elin Rebecka, et al.
Publicado: (2018)

Insights from engraftable immunodeficient mouse models of hyperinsulinaemia
por: Maugham, Michelle L., et al.
Publicado: (2017)

Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia
por: Hufnagel, Antonia, et al.
Publicado: (2022)

The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults
por: Nilsson, Malin, et al.
Publicado: (2019)

Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial
por: Thomsen, Mads N., et al.
Publicado: (2022)

Severe Diltiazem Poisoning Treated with Hyperinsulinaemia-Euglycaemia and Lipid Emulsion
por: Monteiro, Nadine, et al.
Publicado: (2013)

Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
por: Hodson, Leanne, et al.
Publicado: (2019)

Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension
por: Fenger, Mogens, et al.
Publicado: (2011)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?
por: Guildford, Lynda, et al.
Publicado: (2020)

Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2
por: Fenger, Mogens, et al.
Publicado: (2016)

Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation
por: Schroder, Jakob, et al.
Publicado: (2019)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
por: Hernández-Yero, Arturo, et al.
Publicado: (2012)

Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas
por: Cooper, Isabella D., et al.
Publicado: (2021)

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report
por: Knop, Filip K, et al.
Publicado: (2014)

Pulsatile Hyperglycaemia Induces Vascular Oxidative Stress and GLUT 1 Expression More Potently than Sustained Hyperglycaemia in Rats on High Fat Diet
por: Rakipovski, Günaj, et al.
Publicado: (2016)

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study
por: Dejgaard, Thomas Fremming, et al.
Publicado: (2015)

Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men
por: Asmar, Ali, et al.
Publicado: (2017)

Bench-to-bedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers
por: Lheureux, Philippe ER, et al.
Publicado: (2006)

Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity
por: Templeman, Nicole M., et al.
Publicado: (2015)

Correlation of Serum Homocysteine Levels and Hyperinsulinaemia with Body Mass Index in Polycystic Ovarian Syndrome
por: Bhushan, Rashmi, et al.
Publicado: (2022)

Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
por: Bashir, J., et al.
Publicado: (2022)

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake
por: Bojsen-Møller, Kirstine Nyvold, et al.
Publicado: (2023)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture
por: Holst, Jens Juul
Publicado: (2021)

What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?
por: Holst, Jens Juul
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m14fp9ne12c04cagc3doqqritk